Paper16166641
New functions of the major histocompatibility complex class II-specific transcription factor RFXANK revealed by a high-resolution mutagenesis study.
Krawczyk M and 4 others. Mol Cell Biol, 2005. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. New functions of the major histocompatibility complex class II-specific transcription factor RFXANK revealed by a high-resolution mutagenesis study. Papers, record 16166641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16166641
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- New functions of the major histocompatibility complex class II-specific transcription factor RFXANK revealed by a high-resolution mutagenesis study.
- PubMed
Topics29
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Histocompatibility Antigens Class II | Major topic |
| Mutagenesis | Major topic |
| Transcription Factors | Major topic |
| Amino Acid Sequence | |
| Cell Line | |
| Cell Separation | |
| Chromatin | |
| Chromatin Immunoprecipitation | |
| DNA-Binding Proteins | |
| Flow Cytometry | |
| Glutathione Transferase | |
| Humans | |
| Immunoprecipitation | |
| Models, Molecular | |
| Molecular Sequence Data | |
| Mutation | |
| Nuclear Proteins | |
| Plasmids | |
| Promoter Regions, Genetic | |
| Protein Binding | |
| Protein Biosynthesis | |
| Protein Conformation | |
| Protein Structure, Secondary | |
| Protein Structure, Tertiary | |
| RNA, Messenger | |
| Recombinant Fusion Proteins | |
| Sequence Homology, Amino Acid | |
| Trans-Activators | |
| Transcription, Genetic |
Source PubMed
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10725724 | Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells. | J Immunol | 2000 | https://conductscience.org/library/papers/10725724 | PubMed |
| 2 | 15655668 | Evolutionary conservation and characterization of the bare lymphocyte syndrome transcription factor RFX-B and its paralogue ANKRA2. | Immunogenetics | 2005 | https://conductscience.org/library/papers/15655668 | PubMed |
| 3 | 10809673 | CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex. | Genes Dev | 2000 | https://conductscience.org/library/papers/10809673 | PubMed |
| 4 | 10825209 | Mutations in the bare lymphocyte syndrome define critical steps in the assembly of the regulatory factor X complex. | Mol Cell Biol | 2000 | https://conductscience.org/library/papers/10825209 | PubMed |
| 5 | 10913187 | Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter. | Mol Cell Biol | 2000 | https://conductscience.org/library/papers/10913187 | PubMed |
| 6 | 10938095 | Class II transactivator: mastering the art of major histocompatibility complex expression. | Mol Cell Biol | 2000 | https://conductscience.org/library/papers/10938095 | PubMed |
| 7 | 10938133 | Associations and interactions between bare lymphocyte syndrome factors. | Mol Cell Biol | 2000 | https://conductscience.org/library/papers/10938133 | PubMed |
| 8 | 11003667 | CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation. | Mol Cell Biol | 2000 | https://conductscience.org/library/papers/11003667 | PubMed |
| 9 | 11095640 | Characterization of ANKRA, a novel ankyrin repeat protein that interacts with the cytoplasmic domain of megalin. | J Am Soc Nephrol | 2000 | https://conductscience.org/library/papers/11095640 | PubMed |
| 10 | 11244040 | The bare lymphocyte syndrome and the regulation of MHC expression. | Annu Rev Immunol | 2001 | https://conductscience.org/library/papers/11244040 | PubMed |
| 11 | 11256575 | MHC and T cell development. | Rev Immunogenet | 1999 | https://conductscience.org/library/papers/11256575 | PubMed |
| 12 | 11429551 | CIITA coordinates multiple histone acetylation modifications at the HLA-DRA promoter. | Nat Immunol | 2001 | https://conductscience.org/library/papers/11429551 | PubMed |
| 13 | 11463838 | Analysis of ankyrin repeats reveals how a single point mutation in RFXANK results in bare lymphocyte syndrome. | Mol Cell Biol | 2001 | https://conductscience.org/library/papers/11463838 | PubMed |
| 14 | 11486010 | Expression of the three human major histocompatibility complex class II isotypes exhibits a differential dependence on the transcription factor RFXAP. | Mol Cell Biol | 2001 | https://conductscience.org/library/papers/11486010 | PubMed |
| 15 | 11889043 | Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation. | EMBO J | 2002 | https://conductscience.org/library/papers/11889043 | PubMed |
| 16 | 11983150 | Genetic control of MHC class II expression. | Cell | 2002 | https://conductscience.org/library/papers/11983150 | PubMed |
| 17 | 12495741 | Transcriptional regulation of the MHC class II antigen presentation pathway. | Curr Opin Immunol | 2003 | https://conductscience.org/library/papers/12495741 | PubMed |
| 18 | 12498778 | Direct genetic correction as a new method for diagnosis and molecular characterization of MHC class II deficiency. | Mol Ther | 2002 | https://conductscience.org/library/papers/12498778 | PubMed |
| 19 | 12524537 | Chromatin remodeling and extragenic transcription at the MHC class II locus control region. | Nat Immunol | 2003 | https://conductscience.org/library/papers/12524537 | PubMed |
| 20 | 12618906 | Novel mutations in the RFXANK gene: RFX complex containing in-vitro-generated RFXANK mutant binds the promoter without transactivating MHC II. | Immunogenetics | 2003 | https://conductscience.org/library/papers/12618906 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42703166 | Profiling neoadjuvant therapy response in rectal cancer using meta-analysis of publicly available transcriptomic RNA-seq datasets. | Mol Oncol | 2026 | https://conductscience.org/library/papers/42703166 | PubMed |
| 41098223 | Unmasking MHC Class II Deficiency: A Novel Mutation in a Child with Pediatric ARDS due to Pneumocystis Jirovecii Pneumonia. | EJIFCC | 2025 | https://conductscience.org/library/papers/41098223 | PubMed |
| 39277599 | Orientia tsutsugamushi Ank5 promotes NLRC5 cytoplasmic retention and degradation to inhibit MHC class I expression. | Nat Commun | 2024 | https://conductscience.org/library/papers/39277599 | PubMed |
| 39181888 | p53 target ANKRA2 cooperates with RFX7 to regulate tumor suppressor genes. | Cell Death Discov | 2024 | https://conductscience.org/library/papers/39181888 | PubMed |
| 37584719 | Clinical, Immunological, and Genetic Findings in Iranian Patients with MHC-II Deficiency: Confirmation of c.162delG RFXANK Founder Mutation in the Iranian Population. | J Clin Immunol | 2023 | https://conductscience.org/library/papers/37584719 | PubMed |
| 34718924 | Effect of selected single nucleotide polymorphisms in SLC11A1, ANKRA2, IFNG and PGLYRP1 genes on host susceptibility to Mycobacterium avium subspecies paratuberculosis infection in Indian cattle. | Vet Res Commun | 2022 | https://conductscience.org/library/papers/34718924 | PubMed |
| 31877963 | Review on Genomic Regions and Candidate Genes Associated with Economically Important Production and Reproduction Traits in Sheep (Ovies aries). | Animals (Basel) | 2019 | https://conductscience.org/library/papers/31877963 | PubMed |
| 26634365 | Major Histocompatibility Complex Class II Deficiency due to a Novel Mutation in RFXANK in a Child of Mexican Descent. | J Clin Immunol | 2016 | https://conductscience.org/library/papers/26634365 | PubMed |
| 21215266 | Functional analysis of Rfx6 and mutant variants associated with neonatal diabetes. | Dev Biol | 2011 | https://conductscience.org/library/papers/21215266 | PubMed |
| 17175541 | Expression of RAB4B, a protein governing endocytic recycling, is co-regulated with MHC class II genes. | Nucleic Acids Res | 2007 | https://conductscience.org/library/papers/17175541 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ANKRA2 | 57763 | PubTator's text mining | https://conductscience.org/library/genes/57763 | NCBI Gene |
| CIITA | 4261 | PubTator's text mining | https://conductscience.org/library/genes/4261 | NCBI Gene |
| RFX1 | 5989 | PubTator's text mining | https://conductscience.org/library/genes/5989 | NCBI Gene |
| RFX5 | 5993 | PubTator's text mining | https://conductscience.org/library/genes/5993 | NCBI Gene |
| RFXANK | 8625 | PubTator's text mining | https://conductscience.org/library/genes/8625 | NCBI Gene |
| RFXAP | 5994 | PubTator's text mining | https://conductscience.org/library/genes/5994 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16166641
GET https://conductscience.org/api/papers/v1/16166641/references?page=2